Hypothesis	0	10	O
:	10	11	O
Induced	12	19	O
angiogenesis	20	32	O
after	33	38	O
surgery	39	46	O
in	47	49	O
premenopausal	50	63	O
node	64	68	O
-	68	69	O
positive	69	77	O
breast	78	84	B-Pathological_formation
cancer	85	91	I-Pathological_formation
patients	92	100	B-Organism
is	101	103	O
a	104	105	O
major	106	111	O
underlying	112	122	O
reason	123	129	O
why	130	133	O
adjuvant	134	142	O
chemotherapy	143	155	O
works	156	161	O
particularly	162	174	O
well	175	179	O
for	180	183	O
those	184	189	O
patients	190	198	B-Organism
.	198	199	O

BACKGROUND	201	211	O
:	211	212	O
We	213	215	O
suggest	216	223	O
that	224	228	O
surgical	229	237	O
extirpation	238	249	O
of	250	252	O
primary	253	260	O
breast	261	267	B-Pathological_formation
cancer	268	274	I-Pathological_formation
among	275	280	O
other	281	286	O
effects	287	294	O
accelerates	295	306	O
relapse	307	314	O
for	315	318	O
some	319	323	O
premenopausal	324	337	O
node	338	342	O
-	342	343	O
positive	343	351	O
patients	352	360	B-Organism
.	360	361	O

These	362	367	O
accelerated	368	379	O
relapses	380	388	O
occur	389	394	O
within	395	401	O
10	402	404	O
months	405	411	O
of	412	414	O
surgery	415	422	O
for	423	426	O
untreated	427	436	O
patients	437	445	B-Organism
.	445	446	O

The	447	450	O
mechanism	451	460	O
proposed	461	469	O
is	470	472	O
a	473	474	O
stimulation	475	486	O
of	487	489	O
angiogenesis	490	502	O
for	503	506	O
distant	507	514	B-Pathological_formation
dormant	515	522	I-Pathological_formation
micrometastases	523	538	I-Pathological_formation
.	538	539	O

This	540	544	O
has	545	548	O
been	549	553	O
suggested	554	563	O
as	564	566	O
one	567	570	O
of	571	573	O
the	574	577	O
mechanisms	578	588	O
to	589	591	O
explain	592	599	O
the	600	603	O
mammography	604	615	O
paradox	616	623	O
for	624	627	O
women	628	633	B-Organism
aged	634	638	O
40	639	641	O
-	641	642	O
49	642	644	O
years	645	650	O
.	650	651	O

We	652	654	O
could	655	660	O
imagine	661	668	O
that	669	673	O
it	674	676	O
also	677	681	O
plays	682	687	O
a	688	689	O
role	690	694	O
in	695	697	O
adjuvant	698	706	O
chemotherapy	707	719	O
effectiveness	720	733	O
since	734	739	O
,	739	740	O
perhaps	741	748	O
not	749	752	O
coincidentally	753	767	O
,	767	768	O
this	769	773	O
is	774	776	O
most	777	781	O
beneficial	782	792	O
for	793	796	O
premenopausal	797	810	O
node	811	815	O
-	815	816	O
positive	816	824	O
patients	825	833	B-Organism
.	833	834	O

HYPOTHESIS	835	845	O
:	845	846	O
We	847	849	O
speculate	850	859	O
that	860	864	O
there	865	870	O
is	871	873	O
a	874	875	O
burst	876	881	O
of	882	884	O
angiogenesis	885	897	O
of	898	900	O
distant	901	908	B-Pathological_formation
dormant	909	916	I-Pathological_formation
micrometastases	917	932	I-Pathological_formation
after	933	938	O
surgery	939	946	O
in	947	949	O
approximately	950	963	O
20	964	966	O
%	966	967	O
of	968	970	O
premenopausal	971	984	O
node	985	989	O
-	989	990	O
positive	990	998	O
patients	999	1007	B-Organism
.	1007	1008	O

We	1009	1011	O
also	1012	1016	O
speculate	1017	1026	O
that	1027	1031	O
this	1032	1036	O
synchronizes	1037	1049	O
them	1050	1054	O
into	1055	1059	O
a	1060	1061	O
temporal	1062	1070	O
highly	1071	1077	O
chemosensitive	1078	1092	O
state	1093	1098	O
and	1099	1102	O
is	1103	1105	O
the	1106	1109	O
underlying	1110	1120	O
reason	1121	1127	O
why	1128	1131	O
adjuvant	1132	1140	O
chemotherapy	1141	1153	O
works	1154	1159	O
particularly	1160	1172	O
well	1173	1177	O
for	1178	1181	O
that	1182	1186	O
patient	1187	1194	B-Organism
category	1195	1203	O
.	1203	1204	O

Furthermore	1205	1216	O
,	1216	1217	O
this	1218	1222	O
may	1223	1226	O
explain	1227	1234	O
why	1235	1238	O
cancer	1239	1245	O
in	1246	1248	O
younger	1249	1256	O
patients	1257	1265	B-Organism
is	1266	1268	O
more	1269	1273	O
often	1274	1279	O
'	1280	1281	O
aggressive	1281	1291	O
'	1291	1292	O
.	1292	1293	O

TESTING	1294	1301	O
THE	1302	1305	O
HYPOTHESIS	1306	1316	O
:	1316	1317	O
Stimulation	1318	1329	O
of	1330	1332	O
dormant	1333	1340	B-Pathological_formation
micrometastases	1341	1356	I-Pathological_formation
by	1357	1359	O
primary	1360	1367	O
tumor	1368	1373	B-Pathological_formation
removal	1374	1381	O
is	1382	1384	O
known	1385	1390	O
to	1391	1393	O
occur	1394	1399	O
in	1400	1402	O
animal	1403	1409	O
models	1410	1416	O
.	1416	1417	O

However	1418	1425	O
,	1425	1426	O
we	1427	1429	O
need	1430	1434	O
to	1435	1437	O
determine	1438	1447	O
whether	1448	1455	O
it	1456	1458	O
happens	1459	1466	O
in	1467	1469	O
breast	1470	1476	B-Pathological_formation
cancer	1477	1483	I-Pathological_formation
.	1483	1484	O

Transient	1485	1494	O
circulating	1495	1506	O
levels	1507	1513	O
of	1514	1516	O
angioactive	1517	1528	O
molecules	1529	1538	O
and	1539	1542	O
serial	1543	1549	O
high	1550	1554	O
-	1554	1555	O
resolution	1555	1565	O
imaging	1566	1573	O
studies	1574	1581	O
of	1582	1584	O
focal	1585	1590	O
angiogenesis	1591	1603	O
might	1604	1609	O
help	1610	1614	O
.	1614	1615	O

IMPLICATIONS	1616	1628	O
:	1628	1629	O
Short	1630	1635	O
-	1635	1636	O
course	1636	1642	O
cytotoxic	1643	1652	O
chemotherapy	1653	1665	O
after	1666	1671	O
surgery	1672	1679	O
has	1680	1683	O
probably	1684	1692	O
reached	1693	1700	O
its	1701	1704	O
zenith	1705	1711	O
,	1711	1712	O
and	1713	1716	O
other	1717	1722	O
strategies	1723	1733	O
,	1733	1734	O
perhaps	1735	1742	O
antiangiogenic	1743	1757	O
methods	1758	1765	O
,	1765	1766	O
are	1767	1770	O
needed	1771	1777	O
to	1778	1780	O
successfully	1781	1793	O
treat	1794	1799	O
more	1800	1804	O
patients	1805	1813	B-Organism
.	1813	1814	O

In	1815	1817	O
addition	1818	1826	O
,	1826	1827	O
the	1828	1831	O
hypothesis	1832	1842	O
predicts	1843	1851	O
that	1852	1856	O
early	1857	1862	O
detection	1863	1872	O
,	1872	1873	O
which	1874	1879	O
is	1880	1882	O
designed	1883	1891	O
to	1892	1894	O
find	1895	1899	O
more	1900	1904	O
patients	1905	1913	B-Organism
without	1914	1921	O
involved	1922	1930	O
lymph	1931	1936	B-Multi-tissue_structure
nodes	1937	1942	I-Multi-tissue_structure
,	1942	1943	O
may	1944	1947	O
not	1948	1951	O
be	1952	1954	O
a	1955	1956	O
synergistic	1957	1968	O
strategy	1969	1977	O
with	1978	1982	O
adjuvant	1983	1991	O
chemotherapy	1992	2004	O
,	2004	2005	O
which	2006	2011	O
works	2012	2017	O
best	2018	2022	O
with	2023	2027	O
positive	2028	2036	O
lymph	2037	2042	B-Multi-tissue_structure
node	2043	2047	I-Multi-tissue_structure
patients	2048	2056	B-Organism
.	2056	2057	O

